Molecular imaging of DNA synthesis using a new PET tracer: clinical study of diagnosis for cardiac sarcoidosis
Not Applicable
- Conditions
- Cardiac sarcoidosis
- Registration Number
- JPRN-UMIN000030642
- Lead Sponsor
- ational Center for Global Health and Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 95
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patient who is in emargency status 2) Patient with severe comorbid disease including liver dysfunction, renal dysfunction or metabolic damage. 3) Patient with severe mental disease. 4) Patient who have possibility of pregnant, during lactation 5) Patient who have history of allergy to thyothyidine and thymidine 6) Those who are determined as not appropriate for the study by the principal investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To explore how 4DST-PET can contribute to diagnosis of cardiac sarcoidosis, compared to FDG-PET.
- Secondary Outcome Measures
Name Time Method